PARÍS–(BUSINESS WIRE)–Al igual que otros científicos famosos antes que él, Vincent Hayward, cofundador de Actronika, una start-up especializada en tecnología háptica, ha sido invitado a unirse a la prestigiosa Academia de Ciencias. Creada en 1966 por…
Author: Business Wire
ELT Sight Announces Scientific Advisory Board
LOS ANGELES & MUNICH–(BUSINESS WIRE)–ELT Sight brings together glaucoma key opinion leaders to form Scientific Advisory Board and advance ExTra ELT
Kala Pharmaceuticals Announces Completion of Enrollment of STRIDE 3 Trial for EYSUVIS™ (KPI-121 0.25%) for Dry Eye Disease
WATERTOWN, Mass.–(BUSINESS WIRE)–Kala Pharmaceuticals, Inc. (Kala) (NASDAQ:KALA), a biopharmaceutical company focused on the development and commercialization of therapeutics using its proprietary AMPPLIFY™ mucus-penetrating particle (MPP) Drug Deliv…
Vincent Hayward, Co-founder of Actronika, Elected to the Academy of Sciences
PARIS–(BUSINESS WIRE)– #actronika–Vincent Hayward, co-founder of Actronika, a start-up specializing in haptics, has been invited to join the prestigious Academy of Sciences.
Vincent Hayward, co-fondateur d’Actronika, élu à l’Académie des sciences
PARIS–(BUSINESS WIRE)– #actronika–Des années après les célèbres Condorcet, Pasteur ou Pierre Curie, c’est à Vincent Hayward, co-fondateur de la start-up spécialisée dans l’haptique Actronika, de rejoindre la prestigieuse Académie des sciences. Créée…
Immervision gibt neue Lizenzvereinbarungen mit Objektivherstellern ACE Solutech Co. (Korea) und Zhonglan Electronic Technology Co., Ltd (ZET in China) bekannt
MONTREAL–(BUSINESS WIRE)–Immervision, der in Montreal ansässige Entwickler und Lizenzgeber von patentierten Weitwinkeloptiken und Bildgebungstechnologien, kündigt zwei neue Lizenzvereinbarungen für die Produktion und den Vertrieb von patentierten Pan…
Immervision annuncia nuovi accordi di licenza con i produttori di lenti ACE Solutech Co., Ltd. (Corea) e Zhonglan Electronic Technology Co., Ltd (ZET in Cina)
MONTREAL–(BUSINESS WIRE)–Immervision, lo sviluppatore e licenziatario di tecnologia ottica e di imaging grandangolare brevettata con sede a Montreal, annuncia due nuovi accordi di licenza per la produzione e la distribuzione di lenti grandangolari pa…
My Eyelab Ranked a Top Franchise in Entrepreneur’s Highly Competitive 41st Annual Franchise 500®
PALM SPRINGS, Fla.–(BUSINESS WIRE)– #MyEyelab–My Eyelab, a retail brand of Now Optics – a leading eye care provider – recently ranked in Entrepreneur magazine’s Franchise 500®.
Immervision Announces New Licensing Agreements with Lens Manufacturers ACE Solutech Co., Ltd. (Korea) and Zhonglan Electronic Technology Co., Ltd (ZET in China)
MONTREAL–(BUSINESS WIRE)–Immervision, the Montreal-based developer and licensor of patented, wide-angle optics and imaging technology announces two new licensing agreements for the production and distribution of patented panomorph wide-angle lenses w…
Global Eyeglasses Market 2020-2024 | 7% CAGR Projection Over the Next Five Years | Technavio
LONDON–(BUSINESS WIRE)– #ApparelsandAccessories–The eyeglasses market size is expected to post a CAGR of over 7% during the period 2020-2024 according to Technavio
Aldeyra Therapeutics Appoints Nancy Miller-Rich to Board of Directors
LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated diseases, today an…
Horizon Therapeutics plc Increases Peak U.S. Annual Net Sales Expectations for Key Growth Drivers; Provides Update on Several Pipeline Programs
DUBLIN–(BUSINESS WIRE)–Horizon Therapeutics plc (Nasdaq: HZNP) announced today that it is increasing the peak U.S. annual net sales expectations for its key growth drivers KRYSTEXXA and teprotumumab, as well as providing several pipeline updates. “As…
STAAR Surgical Reports Preliminary Fourth Quarter Net Sales Growth of 25%
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today provided preliminary results for the fourth quarter and …
STAAR Surgical Gains Supplemental Lens Approval for EVO Visian ICL to Target Post-Cataract Market Opportunity
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, is today announcing the Company has gained CE Mark approval fo…
OptiKira, Leader in Unfolded Protein Response Therapeutics to Present at the BIOTECH SHOWCASE, January 13, 2020
RADNOR, Pa.–(BUSINESS WIRE)– #JPM20–OptiKira, Leader in Unfolded Protein Response Therapeutics to Present at the Biotech Showcase, January 13, 2020
North America Vision Care Market to Generate a Value of US $28.2 Billion by End of Forecast Period, 2019-2024 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “North America Vision Care Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024” report has been added to ResearchAndMarkets.com’s offering. The publisher expects the market to reach a value of U…
Haymarket Medical Education Receives Interprofessional Joint Accreditation for the Healthcare Team
PARAMUS, N.J.–(BUSINESS WIRE)– #CME–Caroline O. Pardo, Ph.D., General Manager for Haymarket Medical Education (HME), is pleased to announce that HME, based in Paramus, NJ, has been accredited as a provider of interprofessional continuing education (…
Gemini Therapeutics Enrolls First Patient in Phase 1 Study of GEM103 for Dry Age-related Macular Degeneration
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Gemini Therapeutics has enrolled the first patient in its Phase 1 study of GEM103 for dry age-related macular degeneration.
Topical Ocular Formulation of Aerpio Pharmaceutical’s AKB-9778 Product Candidate Produced IOP Lowering with Minimal Hyperemia When Combined with Prostaglandin in Subjects with Primary Open Angle Glaucoma or Ocular Hypertension in Phase 1b Trial
CINCINNATI–(BUSINESS WIRE)–Aerpio Pharmaceuticals, Inc. (Nasdaq: ARPO), a biopharmaceutical company focused on developing compounds that activate Tie2 to treat ocular diseases and diabetic complications, today announced new results from the fifth coh…
Kala Pharmaceuticals to Present at 38th Annual J.P. Morgan Healthcare Conference
WATERTOWN, Mass.–(BUSINESS WIRE)–Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the development and commercialization of therapeutics using its proprietary AMPPLIFY™ mucus-penetrating particle (MPP) Drug Delivery Tec…